45 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
14 May 24
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
7:45am
and the period in which Xilio expects to have cash to fund its operations; and Xilio’s strategy, goals and anticipated financial performance
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
1 Apr 24
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
4:15pm
cash and cash equivalents and the period in which Xilio expects to have cash to fund its operations; and Xilio’s strategy, goals and anticipated
8-K
EX-99.1
so9pmnrh8r 24rl4jx
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
n3i8ud 88
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-99.2
25y04k9xtu9r5iu8
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
2e7tpb3 9esa
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
8-K
t20ssclz xcmgbj
7 Dec 23
Other Events
7:45am
8-K
EX-99.1
kdrqzq ad
7 Dec 23
Other Events
7:45am
8-K
EX-99.1
0i3h o0x103gox
9 Nov 23
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
4:13pm
8-K
gz5efmm2m41 uaz0i
3 Nov 23
Other Events
4:05pm
8-K
EX-99.1
8xb5yks8oow4
3 Nov 23
Other Events
4:05pm
8-K
EX-99.1
a3n25ur35hiiqgs59
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-99.2
exsvjn494z6058z1
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.1
0a05k9a3mmiyxzj
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.2
qgqg0o
25 May 23
Regulation FD Disclosure
5:05pm